Skip to main content
INVENTURUS KNOWLEDGE SOLUTIONS LIMITED logo

INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Investor Relations & Filings

Ticker · IKS ISIN · INE115Q01022 LEI · 3358007O1GXF6BHBQX79 BSE.NS Administrative and support service activities
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-07-31 Board/Management Inform…
Country IN India
Listing BSE.NS IKS

About INVENTURUS KNOWLEDGE SOLUTIONS LIMITED

https://ikshealth.com/

Inventurus Knowledge Solutions Limited, operating as IKS Health, provides administrative and clinical support solutions for healthcare organizations. The company offers a suite of services designed to manage the business functions of medical practices, including revenue cycle management, clinical documentation, and practice optimization. Key products include virtual scribing services, medical coding, and billing solutions that streamline provider workflows. The company also provides value-based care support and population health management tools to improve clinical outcomes and financial sustainability. By leveraging a combination of technology and domain expertise, the platform addresses administrative burdens, allowing clinicians to focus on patient care while enhancing operational efficiency and data accuracy across the care continuum.

Recent filings

Filing Released Lang Actions
Change in Director(s)
Board/Management Information Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding changes in the company's board of directors and senior management. It details appointments and resignations of directors, including designations such as Global CEO, Additional Director (Non-Executive, Non-Independent), Whole-time Director, and Independent Director. The document references compliance with SEBI Listing Regulations and includes annexures with detailed disclosures about each director's appointment or resignation. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on changes in the company's board and management structure, which aligns with the category for announcements of changes in the company's board of directors or senior management.
2025-07-31 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing the appointment of key managerial personnel authorized to assess materiality of events and make disclosures under SEBI LODR Regulation 30. It is a regulatory disclosure about management roles and compliance procedures, not a financial report, earnings release, or meeting material. The document length is short (1642 characters) and it is an announcement of a management-related update. This fits the category of Board/Management Information (MANG), which covers announcements of changes or appointments in senior management or board members.
2025-07-31 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation' and is addressed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating it is a regulatory filing related to investor communication. The content includes detailed financial results for the quarter ended June 30, 2025, with extensive financial data, strategic information, client wins, and operational metrics. The document length is about 15,000 characters, which is substantial and contains actual financial data and analysis, not just an announcement or a brief summary. The presence of detailed quarterly financial results and strategic outlook aligns with the characteristics of an Investor Presentation rather than an Earnings Release or Interim Report, which are typically more concise and focused on financial highlights. Therefore, the document is best classified as an Investor Presentation (IP).
2025-07-31 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated July 31, 2025, announcing the financial results for the quarter ended June 30, 2025. It contains detailed financial data such as revenue, EBITDA, PAT, and growth percentages, as well as business highlights and management commentary. The presence of comprehensive quarterly financial results and analysis indicates this is a quarterly earnings release rather than a full interim report or annual report. The document is not merely an announcement of a report being published but includes substantive financial data and management discussion. Therefore, it fits the definition of an Earnings Release (ER).
2025-07-31 English
Outcome of Board Meeting
Regulatory Filings
2025-07-31 English
Outcome of Board Meeting
Regulatory Filings
2025-07-31 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.